Five Prime Therapeutics Becomes Oversold (FPRX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.

In trading on Friday, shares of Five Prime Therapeutics, Inc ( FPRX) entered into oversold territory, hitting an RSI reading of 29.1, after changing hands as low as $10.50 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 63.8. A bullish investor could look at FPRX's 29.1 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of FPRX shares:

START SLIDESHOW:
Find out what 9 other oversold stocks you need to know about »

Five Prime Therapeutics, Inc 1 Year Performance Chart

Looking at the chart above, FPRX's low point in its 52 week range is $8.02 per share, with $23.33 as the 52 week high point — that compares with a last trade of $10.73.

If you liked this article you might like

Sarepta Rises as FDA Clears Investigational Drug Application -- Biotech Movers

Sarepta Rises as FDA Clears Investigational Drug Application -- Biotech Movers

Biotech Only Sector in the Red as Trump Vows to Crackdown on Drug Pricing, Biggest Movers

Biotech Only Sector in the Red as Trump Vows to Crackdown on Drug Pricing, Biggest Movers

Today Five Prime Therapeutics (FPRX) Hits New Lifetime High

Today Five Prime Therapeutics (FPRX) Hits New Lifetime High

Five Prime Therapeutics (FPRX) Is Today's Strong On High Volume Stock

Five Prime Therapeutics (FPRX) Is Today's Strong On High Volume Stock

3 Small Biotechs That Look Very Healthy

3 Small Biotechs That Look Very Healthy